-
Intravenous iron improved long-term outcomes for people with heart failure and iron deficiency
[ad_1] Research Highlights: Repeated intravenous (IV) administration of iron reduced the risk of hospitalization for heart failure and cardiovascular death…
Read More » -
New medicine reduces triglyceride by 25%, no change in CVD risk in people with Type 2 diabetes
[ad_1] Research Highlights: A new cholesterol medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes, however, there was…
Read More » -
Todos Medical Announces BioFuture NYC 2022 Presentation
[ad_1] New York, NY, and Tel Aviv, ISRAEL – (NewMediaWire) – November 4, 2022 – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive…
Read More » -
News
Golden Matrix Acquires Remaining Interest in RKings Competitions
[ad_1] LAS VEGAS, NV – (NewMediaWire) – November 04, 2022 – Golden Matrix Group Inc. (NASDAQ:GMGI), a developer and licensor…
Read More » -
News
iDPRT Provides Solutions for Massive Nucleic Acid Assay
[ad_1] New York, NY – (NewMediaWire) – November 4, 2022 – iDPRT and Dehong Epidemic Prevention Center work together to purchase…
Read More »
Trending Tickers
WISH
$9.18
27.72%
WISH
$9.18
27.72%
WISH
$9.18
27.72%
Follow us on Twitter